講演・口頭発表等 - 田中　一

81. Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.17 Denmark

82. Matsuoka Y, Tanaka H, Kimura T, Ito M, Inoue M, Kijima T, Yoshida S,. MRI-targeted biopsy vs. systematic biopsy in prediction of biochemical　recurrence after radical prostatectomy. 第105回日本泌尿器科学会総会 2017.04.21 Kagoshima

83. 田中一,吉田宗一郎,井上雅晴,伊藤将也,木島敏樹,横山みなと,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 膀胱癌の免疫組織化学染色に基づく分子サブタイプ分類と化学放射線療法感受性及び予後の解析：筋層浸潤膀胱癌に対する新たな治療戦略に向けて. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

84. 川村尚子,横山みなと,中山貴之,田中一,井上雅晴,伊藤将也,木島敏樹,吉田宗一郎,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 無阻血腎部分切除後の急性腎障害：発生率と術後腎機能への影響. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島、日本

85. 吉田宗一郎、高原太郎、石井千佳子、田中一、井上雅晴、伊藤将也、木島敏樹、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. DWIBS法による全身拡散強調MRIを用いた去勢抵抗性前立腺癌の予後評価. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

86. Nakamura Yuki, Tanaka Hajime, Fujii Yasuhisa, Inoue Masaharu,　Ito　Masaya,　Kijima　Toshiki,　Yoshida　Soichiro,　Yokoyama　Minato,　Ishioka　Junichiro,　Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. . 32nd Annual EAU Congress 2017.03.27 London, UK

87. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Inoue M, Ito M, Kijima T, Yoshida. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 32nd Annual EAU Congress 2017.03.27 London

88. N. Kawamura, M. Yokoyama, T. Nakayama, H. Tanaka, M. Inoue, M.Ito, T. Kijima, S. Yoshida, J. Ishioka, Y. Matsuoka, K. Saito, K. Kihara,Fujii Y.. Acute kidney injury after clampless partial nephrectomy:incidence, predictors, and its low impact on intermediate-term renalfunction　. 32nd Annual EAU Congress 2017.03.27 London、England

89. 13.Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 San diego, USA

90. Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 San diego, USA

91. Masaharu Inoue, Fumitaka Koga, Soichiro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Predictive model for therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiotherapy-based bladder-sparing protocol. AUA2016 Annual Meeting 2016.05.09 San Diego, USA

92. Fujii Y et al.. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.08 USA

93. Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07

94. Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA

95. Waseda Y et al. Impact of elevated urinary metanephrine/normetanephrine and impaired glucose tolerance test on the development of hypoglycemia following removal of pheochromocytoma. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego

96. Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Germany

97. Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

98. Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

99. Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

100. 1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Germany